SW
GLSI icon

SkyOak Wealth’s Greenwich LifeSciences GLSI Stock Holding History

SkyOak Wealth’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,388
Closed -$289K – 250
2021
Q3 		$289K Hold
7,388
– – 0.08% 178
2021
Q2 		$332K Sell
7,388
-17
-0.2% -$643 0.09% 156
2021
Q1 		$293K Sell
7,405
-699
-9% -$23.8K 0.08% 172
2020
Q4 		$296K Buy
+8,104
New +$118K 0.09% 167

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SkyOak Wealth's GLSI Position: Q4 2021 in Review

SkyOak Wealth sold out of Greenwich LifeSciences (GLSI) in Q4 2021, closing a stake of 7,388 shares — an estimated $289K sold.

SkyOak Wealth first reported a position in GLSI in Q4 2020 and held it in 4 quarters. The position peaked at $332K in Q2 2021. 35 funds tracked by Wall St. Rank hold GLSI as of Q4 2021.

  • SkyOak Wealth reported no remaining Greenwich LifeSciences position as of Q4 2021 after selling out during the quarter.
  • SkyOak Wealth sold 7,388 Greenwich LifeSciences shares in Q4 2021, an estimated $289K.
  • SkyOak Wealth first reported a position in Greenwich LifeSciences in Q4 2020 and held it in 4 quarters.
  • SkyOak Wealth's Greenwich LifeSciences position peaked at $332K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2021.

Based on SkyOak Wealth's 13F filing for Q4 2021, filed 24 Jan 2022.